Evening of 23rd May 2017
ERYTECH Conference & Cocktail
Presentation by the management of ERYTECH, a biopharmaceutical company in clinical stage that develops innovative therapies in rare forms of cancers and orphan diseases.
Based on its proprietary platform, ERYCAPS, which uses a new technology to encapsulate drugs (especially enzymes) in red blood cells, ERYTECH has developed a portfolio of candidate products addressing markets with strong medical needs.